CN107449748B - High-density lipoprotein cholesterol detection kit and use method thereof - Google Patents
High-density lipoprotein cholesterol detection kit and use method thereof Download PDFInfo
- Publication number
- CN107449748B CN107449748B CN201710681745.2A CN201710681745A CN107449748B CN 107449748 B CN107449748 B CN 107449748B CN 201710681745 A CN201710681745 A CN 201710681745A CN 107449748 B CN107449748 B CN 107449748B
- Authority
- CN
- China
- Prior art keywords
- reagent
- density lipoprotein
- cholesterol
- lipoprotein cholesterol
- good
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010023302 HDL Cholesterol Proteins 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000001514 detection method Methods 0.000 title claims abstract description 25
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 46
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108010089254 Cholesterol oxidase Proteins 0.000 claims abstract description 15
- 239000004094 surface-active agent Substances 0.000 claims abstract description 15
- 102000003992 Peroxidases Human genes 0.000 claims abstract description 9
- 108040007629 peroxidase activity proteins Proteins 0.000 claims abstract description 9
- 239000006084 composite stabilizer Substances 0.000 claims abstract description 8
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 239000005720 sucrose Substances 0.000 claims abstract description 7
- 102000016938 Catalase Human genes 0.000 claims abstract description 6
- 108010053835 Catalase Proteins 0.000 claims abstract description 6
- 108010055297 Sterol Esterase Proteins 0.000 claims abstract description 6
- 102000000019 Sterol Esterase Human genes 0.000 claims abstract description 6
- 239000003755 preservative agent Substances 0.000 claims abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 4
- 102000004316 Oxidoreductases Human genes 0.000 claims abstract description 4
- 108090000854 Oxidoreductases Proteins 0.000 claims abstract description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical class C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 4
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 4
- 239000007853 buffer solution Substances 0.000 claims abstract description 3
- -1 polyoxyethylene Polymers 0.000 claims abstract 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract 3
- 125000002947 alkylene group Chemical group 0.000 claims abstract 3
- 239000001110 calcium chloride Substances 0.000 claims abstract 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000006173 Good's buffer Substances 0.000 claims description 19
- 238000002835 absorbance Methods 0.000 claims description 18
- 239000000243 solution Substances 0.000 claims description 16
- 239000012086 standard solution Substances 0.000 claims description 11
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012295 chemical reaction liquid Substances 0.000 claims description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 108010024636 Glutathione Proteins 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 229960003180 glutathione Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- 229940051841 polyoxyethylene ether Drugs 0.000 claims 2
- 229920000056 polyoxyethylene ether Polymers 0.000 claims 2
- 101710177646 Catalase easC Proteins 0.000 claims 1
- 101710188970 Catalase-2 Proteins 0.000 claims 1
- 101710097430 Catalase-peroxidase Proteins 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 229920000447 polyanionic polymer Polymers 0.000 abstract description 3
- 229920002554 vinyl polymer Polymers 0.000 abstract description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 239000007993 MOPS buffer Substances 0.000 description 12
- 239000000872 buffer Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 9
- 108010010234 HDL Lipoproteins Proteins 0.000 description 8
- 102000015779 HDL Lipoproteins Human genes 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108010004103 Chylomicrons Proteins 0.000 description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 108010062497 VLDL Lipoproteins Proteins 0.000 description 5
- 238000008620 Cholesterol Assay Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 239000007990 PIPES buffer Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/38—Diluting, dispersing or mixing samples
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a high-density lipoprotein cholesterol detection kit and a using method thereof, and relates to the field of biochemical detection. The high-density lipoprotein cholesterol detection kit is high in stability, low in toxicity, high in accuracy and high in precision, and the using method thereof is provided. The kit of the invention comprises a reagent 1: a surfactant; a polyvinyl sulfate salt; sodium lauryl sulfate; a composite stabilizer; calcium chloride; cholesterol oxidase; cholesterol esterase; ascorbic acid oxidase; a catalase; 4-aminoantipyrine; proclin series preservatives; ethylene glycol; sucrose; the rest is buffer solution; reagent 2: a surfactant; a polyoxyethylene alkylene tribenzyl group; ethylene glycol; sucrose; peroxidase, and the like. The kit adopts various mixed surfactants including poloxamer series, polyvinyl sulfate, sodium dodecyl sulfate and the like, and has better specificity and selectivity compared with polyanion adopted by the traditional method.
Description
Technical Field
The invention relates to the field of biochemical detection, in particular to a kit for determining a material by means of determining the chemical and physical properties of the material.
Background
There are many methods for measuring high density lipoprotein cholesterol, and most of the methods in the market at present are homogeneous phase measurement methods, including PEG modified enzyme method, immune separation method, selective inhibition method and scavenging method. Among these, the elimination method is currently considered to be the most ideal and effective measurement method, and includes two types, i.e., a reaction accelerator peroxidase elimination method (SPD method) and a catalase elimination method (CAT method).
The principle of SPD is based on the difference in affinity between lipoproteins and surfactants. In the reagent 1, Chylomicron (CM) in serum is reacted with a reaction accelerator) Very Low Density Lipoprotein (VLDL) and Low Density Lipoprotein (LDL) form a soluble complex, and free cholesterol on the surface layer is converted into H by cholesterol oxidase (CHOD)2O2And is finally eliminated by Peroxidase (POD). The reagent 2 contains special surfactant, and acts on High Density Lipoprotein (HDL) to cleave it, release cholesterol in HDL, react with enzyme reagent and develop color.
The CAT method does not form a soluble complex during the reaction, but reacts cholesterol in CM, VLDL and LDL with an enzyme reagent to produce H under the action of a specific surfactant2O2，H2O2Is decomposed into H by Catalase (CAT)2O and O2When the HDL particles are cleared, sodium azide is added into the reagent 2 to inhibit the activity of CAT, and another surfactant dissociates HDL particles to expose cholesterol, and the HDL particles react with the cholesterol enzyme reagent to develop color.
Disclosure of Invention
The invention aims to solve the technical problem of providing a high-density lipoprotein cholesterol detection kit which has high stability, low toxicity, no generation of precipitate and high accuracy and precision and a using method thereof.
The invention relates to a high density lipoprotein cholesterol detection kit, the said kit includes reagent 1; the reagent 1 comprises: cholesterol oxidase and cholesterol esterase.
Preferably, the kit further comprises reagent 2;
the reagent 1 comprises:
the balance of GOOD' S buffer MOPS (3- (N-morpholine) propanesulfonic acid) (MOPS is the main component of the buffer), and the pH value of the buffer is 7.0;
the reagent 2 comprises:
the rest is GOOD' S buffer MOPS, and the pH value of the buffer is 7.0.
Preferably, the composite stabilizer comprises Tween 8010-13 g/L, glutamic acid 20-30 g/L, glutathione 1-3 g/L, trehalose 50-60 g/L, dodecyl dimethyl betaine 2-6 g/L, lecithin 3-6 g/L and buffer solution 100-120 mmol/L; it is a composite stabilizer of multiple antibodies of application No. 201610166107.2 and a composite stabilizer in a method of use thereof.
Preferably, the reagent 1 comprises:
the balance of GOOD' S buffer MOPS, wherein the pH value of the buffer is 7.0;
the reagent 2 comprises:
the rest is GOOD' S buffer MOPS, and the pH value of the buffer is 7.0.
The detection method related to the detection kit is an SPD clearing method, and the aim of directly detecting HDL-C is fulfilled by utilizing the reaction affinity difference between a surfactant and lipoprotein. The method mainly comprises two steps of reactions: the first reaction step is as follows: uses surfactant, polyanion and divalent cation with special affinity to HDL-C to form soluble complex with Low Density Lipoprotein (LDL), Very Low Density Lipoprotein (VLDL) and Chylomicron (CM) in serum sample, and uses the action of CHOD and CAT to make surface free cholesterol be converted into H2O and O2Is cleared; and a second reaction step: the other surfactant interacts with HDL to cause its cleavage, and generates peroxidation under the action of CHOD and CHERHydrogen, and HDL to C are measured by a color reaction in the presence of Peroxidase (POD) and a color-developing agent.
The invention also relates to a using method of the high-density lipoprotein cholesterol detection kit, which comprises the following steps:
the detection method of the detection kit is a two-point end point method;
(1) uniformly mixing 300 parts of reagent 1 and 3 parts of samples to be detected, and incubating at 37 ℃ to obtain a reaction solution 1;
(2) then 100 parts of reagent 2 is added and mixed evenly to obtain reaction liquid 2, and the absorbance A1 of the reaction liquid 2 is measured;
(3) measuring the absorbance A2 of the reaction solution 2 again after 5min, and measuring the main wavelength to be 600nm and the sub-wavelength to be 700 nm;
(4) measuring the absorbance of the high-density lipoprotein cholesterol standard solution by the operations of the steps (1) to (3) to respectively obtain the absorbance A3 and the absorbance A4, wherein the main wavelength is 600nm, and the auxiliary wavelength is 700 nm;
(5) calculating the absorbance difference, and calculating the concentration of the high-density lipoprotein cholesterol according to formula 1;
formula 1:
high density lipoprotein cholesterol concentration ═ Δ a sample/Δ a standard solution × standard solution concentration;
Δ a sample ═ a2-a 1;
the standard solution of delta A is A4-A3;
the above parts are parts by volume.
The using method of the high-density lipoprotein cholesterol detection kit of the invention is different from the prior art in that:
1. the high-density lipoprotein cholesterol detection kit adopts various mixed surfactants, including poloxamer series, polyvinyl sulfate, sodium dodecyl sulfate and the like, and has better specificity and selectivity compared with polyanion adopted by the traditional method, and a sample can be kept clear in the detection process, thereby avoiding turbidity interference and having no risk of blocking the pipeline of an analysis instrument.
2. The GOOD' S buffer MOPS in the high-density lipoprotein cholesterol detection kit is a zwitterionic buffer, and has the main advantages of not participating and interfering in biochemical reaction processes and having no inhibiting effect on enzymatic reaction and the like. The ethylene glycol, the sucrose and each component in the composite stabilizer added into the reagent can play a role in keeping the stability of the enzyme in the reagent. The added protease inhibitor sodium azide can effectively inhibit the activity of catalase, and the added proclin preservative is a novel biological preservative, has good compatibility with various enzymes, and has good stability and low toxicity.
3. High density lipoprotein cholesterol consists of apolipoproteins, phospholipids, cholesterol and small amounts of fatty acids. The cholesterol oxidase (CHOD) of the present invention is combined with catalase in the first step of the reaction to react free cholesterol and finally produce H2O and O2In the process, CHOD plays a role in clearing, provides a premise for the next reaction of high density cholesterol (HDL-C), removes the interference of non-HDL-C, further improves the accuracy of a determination result, and is more critical to the next reaction; the second step of the reaction, the chromogenic reaction, is the hydrogen peroxide (H) required for this reaction2O2) Needs to be obtained by the reaction of HDL-C under the combined action of CHOD and CHER. In conclusion, cholesterol oxidase and cholesterol esterase play a crucial role in the reaction process.
Drawings
FIG. 1 is a graph showing the linear correlation between the high density lipoprotein cholesterol assay kit of the present invention and a control kit;
FIG. 2 is a graph showing the linear correlation between the control kit and the high density lipoprotein cholesterol assay kit of the present invention;
FIG. 3 is a test OD value scattergram of a control kit;
FIG. 4 is a test OD value scattergram of the high density lipoprotein cholesterol assay kit of the present invention.
Detailed Description
The use of the high density lipoprotein cholesterol assay kit of the present invention and its method of use are further illustrated by the following examples and confirmatory tests.
Example 1
The high-density lipoprotein cholesterol detection kit of the embodiment comprises the following raw materials in proportion:
the kit consists of a reagent 1 and a reagent 2;
the balance of GOOD' S buffer MOPS, wherein the pH value of the buffer is 7.0;
the rest is GOOD' S buffer MOPS, and the pH value of the buffer is 7.0.
Example 2
The high-density lipoprotein cholesterol detection kit of the embodiment comprises the following raw materials in proportion:
the kit consists of a reagent 1 and a reagent 2;
the balance of GOOD' S buffer MOPS, wherein the pH value of the buffer is 7.0;
the rest is GOOD' S buffer MOPS, and the pH value of the buffer is 7.0.
Example 3
The high-density lipoprotein cholesterol detection kit of the embodiment comprises the following raw materials in proportion:
the kit consists of a reagent 1 and a reagent 2;
the balance of GOOD' S buffer MOPS, wherein the pH value of the buffer is 7.0;
the rest is GOOD' S buffer MOPS, and the pH value of the buffer is 7.0.
Example 4
The detection of high density lipoprotein cholesterol in samples using the products prepared in examples 1-3 was carried out as follows:
(1) uniformly mixing 300 parts of reagent 1 and 3 parts of samples to be detected, and incubating at 37 ℃ to obtain a reaction solution 1;
(2) then 100 parts of reagent 2 is added and mixed evenly to obtain reaction liquid 2, and the absorbance A1 of the reaction liquid 2 is measured;
(3) measuring the absorbance A2 of the reaction solution 2 again after 5min, and measuring the main wavelength to be 600nm and the sub-wavelength to be 700 nm;
(4) measuring the absorbance of the high-density lipoprotein cholesterol standard solution by the operations of the steps (1) to (3) to respectively obtain the absorbance A3 and the absorbance A4, wherein the main wavelength is 600nm, and the auxiliary wavelength is 700 nm;
(5) calculating the absorbance difference, and calculating the concentration of the high-density lipoprotein cholesterol according to formula 1;
formula 1:
high density lipoprotein cholesterol concentration ═ Δ a sample/Δ a standard solution × standard solution concentration;
Δ a sample ═ a2-a 1;
the standard solution of delta A is A4-A3;
the above parts are parts by volume.
Verification test
The products of examples 1-3 were tested and compared with other companies of the same type, and the results are shown in Table 1.
TABLE 1 comparison of the parameters of the kit of the invention and the control kit
| Linear Range (mmol/L) | Accuracy of | Analytical sensitivity (mmol/L) | |
| Control kit | 0.05～3.88 | ≦±10％ | 2.58 |
| The kit of the |
0～4 | ≦±10％ | 0.9 |
The contrast kit is a domestic commercial HDL-C detection kit, and comprises the following components in parts by weight: the reagent 1 comprises PIPES buffer solution, TOOS, ascorbic acid oxidase and Tween 80; the reagent 2 comprises PIPES buffer solution, 4-AAP, CHOD, CHER and POD.
Preparing standard samples with different concentrations of high-density lipoprotein cholesterol, wherein the concentrations are respectively 0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5 and 4.0mmol/L, and respectively measuring the concentrations by using the kit and the control kit. The results are shown in Table 2.
TABLE 2 Linear Range comparison
The results show that: when the sample concentration is not less than 3.0mmol/L, the control kit cannot be detected due to the small linear range, so that the linear range of the kit is wider.
The control kit and the kit of the invention are used as materials, Landau calibrators are used for calibration, and Roche high-value and Roche low-value quality control is used for measurement, and the results are shown in Table 3.
TABLE 3 comparison of accuracy
The results show that: the test result of the kit is closer to the target value, and the accuracy is higher than that of a control kit.
Internal precision: the measurement was repeated 10 times (n is 10) using high and low roche quality control samples, respectively, and the coefficient of variation (CV%) value was calculated. The details are shown in Table 4.
TABLE 4 comparison of in-batch precision
From the results of the above table it can be seen that: the kit of the invention has higher batch precision than a control kit.
The results of the measurement by using a Beckmann AU480 biochemical analyzer, the kit and the control kit as materials, the calibration by using Landau calibrators and the measurement of the HDL-C content of 40 clinical samples show that the test results of the kit have good correlation with the results obtained by using the control reagent, and are shown in Table 5.
TABLE 5 Linear correlation comparison
While specific embodiments of the invention have been described above, it will be appreciated by those skilled in the art that these are by way of example only, and that the scope of the invention is defined by the appended claims. Various changes and modifications to these embodiments may be made by those skilled in the art without departing from the spirit and scope of the invention, and these changes and modifications are within the scope of the invention.
Claims (4)
1. A high density lipoprotein cholesterol detect reagent box which characterized in that: the kit comprises a reagent 1, wherein the reagent 1 comprises: cholesterol oxidase and cholesterol esterase, and the kit also comprises a reagent 2;
the reagent 1 comprises:
1-3 g/L of surfactant poloxamer;
1-10 g/L of polyethylene sulfate;
1-5 g/L of sodium dodecyl sulfate;
1wt% of composite stabilizer;
30-50 g/L of calcium chloride;
5-10 KU/L of cholesterol oxidase;
cholesterol esterase 5-8 KU/L;
ascorbic acid oxidase 3-10 KU/L;
catalase 1-3 KU/L;
1-5 g/L of 4-aminoantipyrine;
0.01-5 g/L proclin series preservative;
15-25 ml/L of ethylene glycol;
10-30 g/L of sucrose;
the balance is GOOD 'S buffer solution, and the pH value of the GOOD' S buffer solution is 7.0;
the reagent 2 comprises:
the surfactant fatty alcohol-polyoxyethylene ether is 2-5 g/L in series;
1-8 g/L of polyoxyethylene alkylene tribenzyl;
15-25 ml/L of ethylene glycol;
10-30 g/L of sucrose;
1-4 KU/L of peroxidase;
1-5 g/L of color developing agent TOPS;
0.01-5 g/L of sodium azide;
the rest is GOOD 'S buffer solution, and the pH value of the GOOD' S buffer solution is 7.0.
2. The high-density lipoprotein cholesterol detection kit according to claim 1, characterized in that: the composite stabilizer comprises Tween 8010-13 g/L, glutamic acid 20-30 g/L, glutathione 1-3 g/L, trehalose 50-60 g/L, dodecyl dimethyl betaine 2-6 g/L, lecithin 3-6 g/L and buffer solution 100-120 mmol/L.
3. The high-density lipoprotein cholesterol detection kit according to claim 1, characterized in that:
the reagent 1 comprises:
the surfactant poloxamer is 2 g/L;
5.5g/L of polyethylene sulfate;
3g/L of sodium dodecyl sulfate;
1wt% of composite stabilizer;
40g/L of calcium chloride;
cholesterol oxidase 7.5 KU/L;
cholesterol esterase 6.5 KU/L;
ascorbic acid oxidase 6.5 KU/L;
catalase 2 KU/L;
3g/L of 4-aminoantipyrine;
proclin series preservative 2.5 g/L;
20ml/L of ethylene glycol;
25g/L of sucrose;
the balance is GOOD 'S buffer solution, and the pH value of the GOOD' S buffer solution is 7.0;
the reagent 2 comprises:
the surfactant fatty alcohol-polyoxyethylene ether series is 3.5 g/L;
4g/L of polyoxyethylene alkylene tribenzyl;
20ml/L of ethylene glycol;
20 g/L of sucrose;
peroxidase 2.5 KU/L;
3g/L of color developing agent TOPS;
2.5g/L of sodium azide;
the rest is GOOD 'S buffer solution, and the pH value of the GOOD' S buffer solution is 7.0.
4. The high-density lipoprotein cholesterol detection kit according to claim 1, characterized in that: the using method comprises the following steps:
(1) uniformly mixing 300 parts of reagent 1 and 3 parts of samples to be detected, and incubating at 37 ℃ to obtain a reaction solution 1;
(2) then 100 parts of reagent 2 is added and mixed evenly to obtain reaction liquid 2, and the absorbance A1 of the reaction liquid 2 is measured;
(3) measuring the absorbance A2 of the reaction solution 2 again after 5min, and measuring the main wavelength to be 600nm and the sub-wavelength to be 700 nm;
(4) measuring the absorbance of the high-density lipoprotein cholesterol standard solution by the operations of the steps (1) to (3) to respectively obtain the absorbance A3 and the absorbance A4, wherein the main wavelength is 600nm, and the auxiliary wavelength is 700 nm;
(5) calculating the absorbance difference, and calculating the concentration of the high-density lipoprotein cholesterol according to formula 1;
formula 1:
high density lipoprotein cholesterol concentration =Δa sample/Δ a standard solution × standard solution concentration;
Δ a sample = a2-a 1;
Δ a standard = a 4-A3;
the above parts are parts by volume.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710681745.2A CN107449748B (en) | 2017-08-10 | 2017-08-10 | High-density lipoprotein cholesterol detection kit and use method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710681745.2A CN107449748B (en) | 2017-08-10 | 2017-08-10 | High-density lipoprotein cholesterol detection kit and use method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN107449748A CN107449748A (en) | 2017-12-08 |
| CN107449748B true CN107449748B (en) | 2020-08-28 |
Family
ID=60491698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710681745.2A Active CN107449748B (en) | 2017-08-10 | 2017-08-10 | High-density lipoprotein cholesterol detection kit and use method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107449748B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108627510A (en) * | 2018-06-06 | 2018-10-09 | 临安卡尔生物技术有限公司 | High-density lipoprotein cholesterol detection kit |
| CN108982383A (en) * | 2018-07-19 | 2018-12-11 | 江西维瑞生物科技有限公司 | lipoprotein cholesterol detection system |
| CN110736846B (en) * | 2018-07-20 | 2023-07-14 | 上海微鸿企业管理有限公司 | Small and dense lipoprotein determination reagent, method and kit |
| CN109580511A (en) * | 2018-12-06 | 2019-04-05 | 潍坊泽成生物技术有限公司 | A kind of detection method and detection kit of high-density lipoprotein cholesterol |
| CN111337440A (en) * | 2018-12-18 | 2020-06-26 | 上海底物生化科技有限公司 | Cardiovascular and cerebrovascular event risk screening kit and detection method thereof |
| CN111595658B (en) * | 2020-06-06 | 2023-11-14 | 宾傲 | Lysate for extracting proteins in cells and preparation method thereof |
| CN111893163B (en) * | 2020-08-06 | 2023-01-17 | 武汉生之源生物科技股份有限公司 | High-density lipoprotein 3 cholesterol detection kit, preparation method and application |
| CN112695071B (en) * | 2020-12-16 | 2022-12-30 | 浙江伊利康生物技术有限公司 | High-density lipoprotein 3 determination reagent, method and kit |
| CN114689878A (en) * | 2020-12-29 | 2022-07-01 | 中元汇吉生物技术股份有限公司 | Low-density lipoprotein LDL-C determination kit for reducing cross contamination |
| CN113308513B (en) * | 2021-05-27 | 2022-02-18 | 宁波瑞源生物科技有限公司 | Small and dense low-density lipoprotein cholesterol detection kit and detection method thereof |
| CN114134202B (en) * | 2021-11-26 | 2022-12-13 | 深圳市雷诺华科技实业有限公司 | Method for measuring high-density lipoprotein cholesterol by using inorganic hybrid nanoflower |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1888863A (en) * | 2005-06-29 | 2007-01-03 | 中生北控生物科技股份有限公司 | High-density lipoprotein cholesterol quantitative determining method, reagent and reagent kit |
| CN101373190A (en) * | 2002-11-27 | 2009-02-25 | 积水医疗株式会社 | Method of measuring lipid in specific lipoprotein |
| CN101551399A (en) * | 2008-04-01 | 2009-10-07 | 北京九强生物技术有限公司 | Quantitative method for high density lipoprotein cholesterol and low density lipoprotein cholesterol |
| EP2116613A1 (en) * | 2007-09-05 | 2009-11-11 | ARKRAY, Inc. | Method of measuring low density lipoprotein (ldl) cholesterol and test piece for measuring ldl cholesterol |
| EP2194142A1 (en) * | 2002-11-27 | 2010-06-09 | Daiichi Pure Chemicals Co., Ltd. | Method of measuring cholesterol in high density lipoproteins |
| WO2012011554A1 (en) * | 2010-07-23 | 2012-01-26 | デンカ生研株式会社 | Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4200102B2 (en) * | 2002-01-30 | 2008-12-24 | デンカ生研株式会社 | Method and reagent composition for determination of cholesterol in high density lipoprotein |
| CN1379235A (en) * | 2002-05-10 | 2002-11-13 | 肖洪武 | Process and reagent for measuring high-density lipoprotein and cholesterol |
| CN104048955A (en) * | 2013-03-11 | 2014-09-17 | 南京澳林生物科技有限公司 | High density lipoprotein cholesterol detection kit |
| CN104076158B (en) * | 2014-07-10 | 2016-08-17 | 深圳市新产业生物医学工程股份有限公司 | A kind of test kit for measuring HDL-C |
| CN105777858B (en) * | 2016-03-22 | 2019-09-10 | 东软威特曼生物科技(南京)有限公司 | The compound stabilizer and its application method of Multiple Antibodies |
| CN106383116B (en) * | 2016-10-21 | 2019-02-01 | 北京世纪沃德生物科技有限公司 | A kind of kit detecting high-density lipoprotein cholesterol |
-
2017
- 2017-08-10 CN CN201710681745.2A patent/CN107449748B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101373190A (en) * | 2002-11-27 | 2009-02-25 | 积水医疗株式会社 | Method of measuring lipid in specific lipoprotein |
| EP2194142A1 (en) * | 2002-11-27 | 2010-06-09 | Daiichi Pure Chemicals Co., Ltd. | Method of measuring cholesterol in high density lipoproteins |
| CN1888863A (en) * | 2005-06-29 | 2007-01-03 | 中生北控生物科技股份有限公司 | High-density lipoprotein cholesterol quantitative determining method, reagent and reagent kit |
| EP2116613A1 (en) * | 2007-09-05 | 2009-11-11 | ARKRAY, Inc. | Method of measuring low density lipoprotein (ldl) cholesterol and test piece for measuring ldl cholesterol |
| CN101551399A (en) * | 2008-04-01 | 2009-10-07 | 北京九强生物技术有限公司 | Quantitative method for high density lipoprotein cholesterol and low density lipoprotein cholesterol |
| WO2012011554A1 (en) * | 2010-07-23 | 2012-01-26 | デンカ生研株式会社 | Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
Non-Patent Citations (2)
| Title |
|---|
| The evolution of selective analyses of HDL and LDL cholesterol in clinical and point of care testing;Termeh Ahmadraji等;《Analytical Methods》;20130807;第3612-3625页 * |
| 高、低密度脂蛋白胆固醇的匀相测定法及技术要求;鄢盛恺;《临床检验杂志》;20021231;第325-328页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN107449748A (en) | 2017-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107449748B (en) | High-density lipoprotein cholesterol detection kit and use method thereof | |
| CN107505272B (en) | Low-density lipoprotein cholesterol detection kit and use method thereof | |
| EP2208794B1 (en) | Method and kit for quantification of small, dense ldl cholesterol | |
| CN109580504B (en) | Lipoprotein cholesterol determination reagent and kit | |
| KR101394802B1 (en) | Reagent for determination of quantity of small dense low-density lipoprotein | |
| CA2260689C (en) | Method for quantifying cholesterol in low density lipoprotein | |
| EP1930442B1 (en) | Method and kit for quantitative determination of small, dense ldl cholesterol | |
| CN105296597B (en) | Kit for detecting high density lipoprotein cholesterol content | |
| AU2005227961B2 (en) | Method of multiquantification for cholesterol of low-density lipoprotein | |
| CN100476401C (en) | High-density lipoprotein cholesterol quantitative determining method, reagent and reagent kit | |
| CN106383116A (en) | Kit for detecting high density lipoprotein cholesterol | |
| US8765394B2 (en) | Method of quantifying cholesterol in high density lipoprotein and reagent compositions | |
| CN107505273A (en) | Serum tolal bile acid assay kit and its application method | |
| CN107446989A (en) | Determine the method and reagent of the sdLDL-C in sample | |
| US7202047B2 (en) | Aqueous method for determining cholesterol in remnant-like particles using cholesterol esterase, phospholipase, surfactant and cholesterol oxidase or dehydrogenase | |
| CN111944872A (en) | Reagent combination, reagent or kit for measuring creatinine content | |
| CN109613282B (en) | High-density lipoprotein cholesterol determination kit and application thereof | |
| TWI731088B (en) | Method of quantifying cholesterol in triglyceride-rich lipoprotein | |
| CN1748036B (en) | Method of multiple quantification of cholesterol in low-density lipoproteins | |
| CN102323225B (en) | Method and reagent kit used for detecting low-density lipoprotein cholesterin | |
| US6991913B1 (en) | Procedure for the determination of triglyceride contained in low density lipoprotein | |
| EP1020532B1 (en) | Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method | |
| US6114134A (en) | Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method | |
| CN104048955A (en) | High density lipoprotein cholesterol detection kit | |
| CN110791549B (en) | Method and kit for quantitatively determining small dense low density lipoprotein cholesterol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| CB02 | Change of applicant information |
Address after: 210039 Building 2, 108 West Road South Road, Yuhuatai District, Nanjing, Jiangsu Applicant after: NEUSOFT WHITMAN BIOTECH (NANJING) Co.,Ltd. Address before: 210039 Building 2, 108 West Road South Road, Yuhuatai District, Nanjing, Jiangsu Applicant before: WHITMAN BIOTECH (NANJING) CO.,LTD. |
|
| CB02 | Change of applicant information | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |